Fingerprint
Dive into the research topics of 'Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trail'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically